Recombinant Human Interleukin-11 for Injection Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1380334 No. of Pages: 77 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Recombinant Human Interleukin-11 for Injection is a drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Recombinant human interleukin-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, oprelvekin, and rhIL-11.
This report contains market size and forecasts of Recombinant Human Interleukin-11 for Injection in global, including the following market information:
Global Recombinant Human Interleukin-11 for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Human Interleukin-11 for Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Human Interleukin-11 for Injection companies in 2021 (%)
The global Recombinant Human Interleukin-11 for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Interleukin-11 for Injection include Xiamen Amoytop Biotech, SL Pharm, Qilu Pharmaceutical, Angde Biotech Pharmaceutical and Hangzhou Jiuyuan Gene Engineering, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Interleukin-11 for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Interleukin-11 for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Human Interleukin-11 for Injection Market Segment Percentages, by Type, 2021 (%)
1mg
1.5mg
3mg
5mg
Other
Global Recombinant Human Interleukin-11 for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Human Interleukin-11 for Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Global Recombinant Human Interleukin-11 for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Human Interleukin-11 for Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Interleukin-11 for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Human Interleukin-11 for Injection revenues share in global market, 2021 (%)
Key companies Recombinant Human Interleukin-11 for Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Human Interleukin-11 for Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Xiamen Amoytop Biotech
SL Pharm
Qilu Pharmaceutical
Angde Biotech Pharmaceutical
Hangzhou Jiuyuan Gene Engineering
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Interleukin-11 for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Interleukin-11 for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Interleukin-11 for Injection Overall Market Size
2.1 Global Recombinant Human Interleukin-11 for Injection Market Size: 2021 VS 2028
2.2 Global Recombinant Human Interleukin-11 for Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Human Interleukin-11 for Injection Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Human Interleukin-11 for Injection Players in Global Market
3.2 Top Global Recombinant Human Interleukin-11 for Injection Companies Ranked by Revenue
3.3 Global Recombinant Human Interleukin-11 for Injection Revenue by Companies
3.4 Global Recombinant Human Interleukin-11 for Injection Sales by Companies
3.5 Global Recombinant Human Interleukin-11 for Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Human Interleukin-11 for Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Human Interleukin-11 for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Interleukin-11 for Injection Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Interleukin-11 for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Interleukin-11 for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Human Interleukin-11 for Injection Market Size Markets, 2021 & 2028
4.1.2 1mg
4.1.3 1.5mg
4.1.4 3mg
4.1.5 5mg
4.1.6 Other
4.2 By Type - Global Recombinant Human Interleukin-11 for Injection Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Interleukin-11 for Injection Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Human Interleukin-11 for Injection Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Human Interleukin-11 for Injection Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Human Interleukin-11 for Injection Sales & Forecasts
4.3.1 By Type - Global Recombinant Human Interleukin-11 for Injection Sales, 2017-2022
4.3.2 By Type - Global Recombinant Human Interleukin-11 for Injection Sales, 2023-2028
4.3.3 By Type - Global Recombinant Human Interleukin-11 for Injection Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Human Interleukin-11 for Injection Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Interleukin-11 for Injection Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Recombinant Human Interleukin-11 for Injection Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Interleukin-11 for Injection Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Human Interleukin-11 for Injection Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Human Interleukin-11 for Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Human Interleukin-11 for Injection Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Interleukin-11 for Injection Sales, 2017-2022
5.3.2 By Application - Global Recombinant Human Interleukin-11 for Injection Sales, 2023-2028
5.3.3 By Application - Global Recombinant Human Interleukin-11 for Injection Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Human Interleukin-11 for Injection Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Human Interleukin-11 for Injection Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Human Interleukin-11 for Injection Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Interleukin-11 for Injection Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Human Interleukin-11 for Injection Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Human Interleukin-11 for Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Human Interleukin-11 for Injection Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Interleukin-11 for Injection Sales, 2017-2022
6.3.2 By Region - Global Recombinant Human Interleukin-11 for Injection Sales, 2023-2028
6.3.3 By Region - Global Recombinant Human Interleukin-11 for Injection Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Human Interleukin-11 for Injection Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Human Interleukin-11 for Injection Sales, 2017-2028
6.4.3 US Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.4.4 Canada Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.4.5 Mexico Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Interleukin-11 for Injection Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Human Interleukin-11 for Injection Sales, 2017-2028
6.5.3 Germany Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5.4 France Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5.5 U.K. Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5.6 Italy Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5.7 Russia Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.5.9 Benelux Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Interleukin-11 for Injection Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Human Interleukin-11 for Injection Sales, 2017-2028
6.6.3 China Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.6.4 Japan Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.6.5 South Korea Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.6.7 India Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Human Interleukin-11 for Injection Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Human Interleukin-11 for Injection Sales, 2017-2028
6.7.3 Brazil Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.7.4 Argentina Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Interleukin-11 for Injection Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Human Interleukin-11 for Injection Sales, 2017-2028
6.8.3 Turkey Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.8.4 Israel Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
6.8.6 UAE Recombinant Human Interleukin-11 for Injection Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Xiamen Amoytop Biotech
7.1.1 Xiamen Amoytop Biotech Corporate Summary
7.1.2 Xiamen Amoytop Biotech Business Overview
7.1.3 Xiamen Amoytop Biotech Recombinant Human Interleukin-11 for Injection Major Product Offerings
7.1.4 Xiamen Amoytop Biotech Recombinant Human Interleukin-11 for Injection Sales and Revenue in Global (2017-2022)
7.1.5 Xiamen Amoytop Biotech Key News
7.2 SL Pharm
7.2.1 SL Pharm Corporate Summary
7.2.2 SL Pharm Business Overview
7.2.3 SL Pharm Recombinant Human Interleukin-11 for Injection Major Product Offerings
7.2.4 SL Pharm Recombinant Human Interleukin-11 for Injection Sales and Revenue in Global (2017-2022)
7.2.5 SL Pharm Key News
7.3 Qilu Pharmaceutical
7.3.1 Qilu Pharmaceutical Corporate Summary
7.3.2 Qilu Pharmaceutical Business Overview
7.3.3 Qilu Pharmaceutical Recombinant Human Interleukin-11 for Injection Major Product Offerings
7.3.4 Qilu Pharmaceutical Recombinant Human Interleukin-11 for Injection Sales and Revenue in Global (2017-2022)
7.3.5 Qilu Pharmaceutical Key News
7.4 Angde Biotech Pharmaceutical
7.4.1 Angde Biotech Pharmaceutical Corporate Summary
7.4.2 Angde Biotech Pharmaceutical Business Overview
7.4.3 Angde Biotech Pharmaceutical Recombinant Human Interleukin-11 for Injection Major Product Offerings
7.4.4 Angde Biotech Pharmaceutical Recombinant Human Interleukin-11 for Injection Sales and Revenue in Global (2017-2022)
7.4.5 Angde Biotech Pharmaceutical Key News
7.5 Hangzhou Jiuyuan Gene Engineering
7.5.1 Hangzhou Jiuyuan Gene Engineering Corporate Summary
7.5.2 Hangzhou Jiuyuan Gene Engineering Business Overview
7.5.3 Hangzhou Jiuyuan Gene Engineering Recombinant Human Interleukin-11 for Injection Major Product Offerings
7.5.4 Hangzhou Jiuyuan Gene Engineering Recombinant Human Interleukin-11 for Injection Sales and Revenue in Global (2017-2022)
7.5.5 Hangzhou Jiuyuan Gene Engineering Key News
8 Global Recombinant Human Interleukin-11 for Injection Production Capacity, Analysis
8.1 Global Recombinant Human Interleukin-11 for Injection Production Capacity, 2017-2028
8.2 Recombinant Human Interleukin-11 for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Interleukin-11 for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Interleukin-11 for Injection Supply Chain Analysis
10.1 Recombinant Human Interleukin-11 for Injection Industry Value Chain
10.2 Recombinant Human Interleukin-11 for Injection Upstream Market
10.3 Recombinant Human Interleukin-11 for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Interleukin-11 for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com